logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

MOBI DEV (00947) spent HK$835 to repurchase 5000 shares on November 4th.

date
16:33 04/11/2025
avatar
GMT Eight
Moby Development (00947) announced that on November 4, 2025, the company will spend 835 million Hong Kong dollars to repurchase 50...
MOBI DEV (00947) announced on November 4, 2025 that the company will spend HK$835 to repurchase 5000 shares at a price of HK$0.166-0.171 per share.
Related Articles
HK Stock
On November 4th, IVD MEDICAL (01931) spent 10.31 million Hong Kong dollars to repurchase 1.823 million shares.
HK Stock
TWINTEK (06182) changes ownership, receives a discount of approximately 74.3% for the complete takeover offer, and is scheduled to resume trading on November 5th.
US Stock
Pfizer Inc. (PFE.US) Q3 earnings exceed expectations and once again raise full-year profit guidance, striving to acquire weight-loss drug company Metsera.
On November 4th, IVD MEDICAL (01931) spent 10.31 million Hong Kong dollars to repurchase 1.823 million shares.
HK Stock
TWINTEK (06182) changes ownership, receives a discount of approximately 74.3% for the complete takeover offer, and is scheduled to resume trading on November 5th.
HK Stock
Pfizer Inc. (PFE.US) Q3 earnings exceed expectations and once again raise full-year profit guidance, striving to acquire weight-loss drug company Metsera.
US Stock
RECOMMEND
World’s largest oil company Aramco posts higher Q3 net profit after lifting output
World’s largest oil company Aramco posts higher Q3 net profit after lifting output
icon
04/11/2025
HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
icon
04/11/2025
Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
icon
04/11/2025
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.